Search results
May 30, 2024 · The first theranostic for Endotoxic Septic Shock: The Endotoxin Activity Assay EAA™ & Toraymyxin Polymyxin B Hemoperfusion PMX cartridge.
At Spectral Medical, we are pioneering a transformative theranostic approach that will enable improved outcomes for patients with endotoxic septic shock (ESS).
Find the latest Spectral Medical Inc. (EDT.TO) stock quote, history, news and other vital information to help you with your stock trading and investing.
5 days ago · TORONTO, July 11, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that MNP LLP (“MNP”) have today been appointed as the auditors of the Company following the decision by PricewaterhouseCoopers LLP (“PwC”) to resign as the auditor of ...
Spectral is a Phase 3 company seeking U.S. FDA approval for its unique product for the treatment of patients with septic shock, Toraymyxin™ (“PMX”). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s Endotoxin Activity Assay (EAA™), the only FDA ...
4 days ago · Spectral Medical Inc. Announces Change to Auditor. TORONTO, July 11, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ( "Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company ...
Feb 15, 2024 · Spectral is a Phase 3 company seeking U.S. FDA approval for its unique product for the treatment of patients with septic shock, Toraymyxin™ (“PMX”).
Feb 21, 2024 · TORONTO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic...
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally.
5 days ago · Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally.
